Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients
Recruiting
N/A
Interventional Study
Atrial Fibrillation and Flutter
Mechanical Mitral Valve Prosthesis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 586 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Oral anticoagulation (OAC) is indicated in a wide variety of clinical conditions including atrial fibrillation (AF), mechanical valve prosthesis (MVP), deep vein thrombosis and pulmonary embolism. Although direct OAC has replaced vitamin K antagonists (VKA) in non-valvular AF due to lower bleeding risk, it's still recommended to use VKA specifically in cases of valvular AF, MVP and anti-phospholip…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients above 18 years who are indicated for long term VKA and has been on VKA for more than 6 months.
Exclusion Criteria:
1. Refusal to join the study.
2. History of prior life-threatening bleeding or thrombo-embolic events.
3. Illiterate patients with no caregivers …
Contacts